In the context of cancer, LAG‐3 has been shown to limit both the accumulation and effector function of CD8+ T cells in tumor tissue,158 and its elevated expression on tumor‐infiltrating Tregs correlates with enhanced immunosuppressive activity by these cells.159, 160. The gene discussed is CD8A; the disease is neoplasm.